348 filings
Page 10 of 18
8-K
9g8c7 hmsp0i
9 Mar 21
INmune Bio, Inc. Announces Participation at Upcoming Virtual Investor Conferences in March 2021
4:04pm
8-K
7pmjghe2 zt6a
5 Mar 21
INmune Bio, Inc. to Report Fourth Quarter and Full Year 2020 Financial Results and Provide a Corporate Update on Thursday, March 4
4:05pm
8-K
5lui2sb01j
2 Mar 21
INmune Bio, Inc. to Report Fourth Quarter and Full Year 2020 Financial Results and Provide a Corporate Update on Thursday, March 4
9:02am
8-K
mljgu7 zovfy65m0
25 Jan 21
Departure of Directors or Certain Officers
4:03pm
8-K
r7dg5v1fbn10yqro2n7a
21 Jan 21
Other Events
4:33pm
8-K
5u1oeejy8hft
21 Jan 21
Other Events
7:12am
8-K
h0vanrmgteifgxp6nokw
19 Jan 21
Other Events
8:00am
8-K/A
o5hw3obb
4 Jan 21
Entry into a Material Definitive Agreement
5:28pm
8-A12B
m3dt9
30 Dec 20
Registration of securities on exchange
5:02pm
8-K
jskb4k
30 Dec 20
Entry into a Material Definitive Agreement
4:57pm
8-K
atehe9yy
30 Dec 20
Other Events
4:52pm
8-K
q6mp8hhb58sis6 241
12 Nov 20
HARNESSING THE POWER OF THE INNATE IMMUNE SYSTEM Modulating an Innate Immune Response Against Diseases IN MB CORPORATE PRESENTATION Nov 2020
12:00am
8-K
hd7mid78p80j
9 Nov 20
Other Events
4:10pm
8-K
bwytkcp cb1f6sn0h
6 Nov 20
INmune Bio, Inc. Announces Third Quarter Results and Provides Business Update
8:30am
8-K
ib3mh2pvvzkt1
27 Oct 20
Other Events
6:03am
8-K
2r332eb7 22u
6 Oct 20
INmune Bio, Inc. Presents Preliminary Phase I Data at 21st International Conference on Alzheimer’s Drug Discovery
8:28am
8-K
8hjl8stpx7
1 Oct 20
Submission of Matters to a Vote of Security Holders
4:10pm
8-K
mzervx6otku lc
29 Sep 20
Forward Looking Statements
12:41pm